Eagle Claw Capital Managment, LLC Thermo Fisher Scientific Inc. Transaction History

Eagle Claw Capital Managment, LLC

  • $573 Million
  • Q3 2024

A detailed history of Eagle Claw Capital Managment, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Eagle Claw Capital Managment, LLC holds 6,284 shares of TMO stock, worth $3.23 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
6,284
Previous 6,359 1.18%
Holding current value
$3.23 Million
Previous $3.52 Million 10.52%
% of portfolio
0.68%
Previous 0.65%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$531.86 - $624.21 $39,889 - $46,815
-75 Reduced 1.18%
6,284 $3.89 Million
Q2 2024

Aug 09, 2024
SELL
$541.52 - $599.02 $51,444 - $56,906
-95 Reduced 1.47%
6,359 $3.52 Million
Q1 2024

May 13, 2024
SELL
$528.82 - $599.43 $79,323 - $89,914
-150 Reduced 2.27%
6,454 $3.75 Million
Q4 2023

Feb 14, 2024
SELL
$431.41 - $532.94 $21,570 - $26,647
-50 Reduced 0.75%
6,604 $3.51 Million
Q3 2023

Nov 07, 2023
SELL
$498.29 - $574.41 $74,743 - $86,161
-150 Reduced 2.2%
6,654 $3.37 Million
Q2 2023

Aug 09, 2023
SELL
$508.46 - $591.13 $88,980 - $103,447
-175 Reduced 2.51%
6,804 $3.55 Million
Q1 2023

May 04, 2023
SELL
$535.0 - $604.82 $56,175 - $63,506
-105 Reduced 1.48%
6,979 $4.02 Million
Q4 2022

Feb 09, 2023
SELL
$484.71 - $571.37 $298,581 - $351,963
-616 Reduced 8.0%
7,084 $3.9 Million
Q4 2022

Feb 06, 2023
BUY
$484.71 - $571.37 $250,110 - $294,826
516 Added 7.18%
7,700 $4.24 Million
Q3 2022

Nov 07, 2022
SELL
$507.19 - $604.49 $38,039 - $45,336
-75 Reduced 1.03%
7,184 $3.64 Million
Q2 2022

Aug 08, 2022
SELL
$500.9 - $612.21 $238,428 - $291,411
-476 Reduced 6.15%
7,259 $3.94 Million
Q1 2022

May 13, 2022
SELL
$524.0 - $644.92 $131,000 - $161,230
-250 Reduced 3.13%
7,735 $4.57 Million
Q4 2021

Feb 14, 2022
SELL
$569.0 - $667.24 $71,125 - $83,405
-125 Reduced 1.54%
7,985 $5.33 Million
Q3 2021

Nov 05, 2021
BUY
$509.53 - $609.78 $443,291 - $530,508
870 Added 12.02%
8,110 $4.63 Million
Q2 2021

Aug 10, 2021
SELL
$441.0 - $508.24 $32,193 - $37,101
-73 Reduced 1.0%
7,240 $3.65 Million
Q1 2021

May 12, 2021
SELL
$439.85 - $518.83 $16,274 - $19,196
-37 Reduced 0.5%
7,313 $3.34 Million
Q3 2020

Nov 09, 2020
SELL
$359.77 - $441.52 $35,977 - $44,152
-100 Reduced 1.34%
7,350 $3.25 Million
Q2 2020

Aug 13, 2020
SELL
$275.2 - $362.34 $82,560 - $108,701
-300 Reduced 3.87%
7,450 $2.7 Million
Q1 2020

May 08, 2020
SELL
$255.3 - $340.05 $12,765 - $17,002
-50 Reduced 0.64%
7,750 $2.2 Million
Q3 2019

Oct 22, 2019
SELL
$268.46 - $305.43 $40,269 - $45,814
-150 Reduced 1.89%
7,800 $2.27 Million
Q2 2019

Jul 18, 2019
SELL
$257.51 - $295.55 $51,502 - $59,110
-200 Reduced 2.45%
7,950 $2.33 Million
Q1 2019

May 01, 2019
SELL
$212.17 - $273.72 $53,042 - $68,430
-250 Reduced 2.98%
8,150 $2.23 Million
Q4 2018

Feb 14, 2019
SELL
$208.47 - $251.98 $20,847 - $25,198
-100 Reduced 1.18%
8,400 $1.88 Million
Q3 2018

Nov 14, 2018
SELL
$205.57 - $244.32 $20,557 - $24,432
-100 Reduced 1.16%
8,500 $2.07 Million
Q2 2018

Aug 14, 2018
SELL
$203.14 - $219.53 $20,314 - $21,953
-100 Reduced 1.15%
8,600 $1.78 Million
Q1 2018

May 18, 2018
SELL
$192.98 - $224.11 $48,245 - $56,027
-250 Reduced 2.79%
8,700 $1.8 Million
Q4 2017

Feb 13, 2018
SELL
$182.03 - $200.37 $13,652 - $15,027
-75 Reduced 0.83%
8,950 $1.7 Million
Q3 2017

Nov 16, 2017
SELL
$171.74 - $194.04 $30,054 - $33,957
-175 Reduced 1.9%
9,025 $1.71 Million
Q2 2017

Aug 15, 2017
BUY
N/A
9,200
9,200 $1.6 Million

Others Institutions Holding TMO

# of Institutions
2,829
Shares Held
334M
Call Options Held
2.37M
Put Options Held
2.75M
View Full List

About THERMO FISHER SCIENTIFIC INC.

TMO Quotes by TradingView
  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Eagle Claw Capital Managment, LLC Portfolio

Follow Eagle Claw Capital Managment, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Claw Capital Managment, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Claw Capital Managment, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email